Andrew Dabbikeh1, Yingwei Peng1, William J Mackillop1, Christopher M Booth1, Jina Zhang-Salomons1. 1. Affiliations: Departments of Public Health Sciences (Dabbikeh, Peng, Mackillop, Zhang-Salomons) and Oncology (Mackillop, Booth, Zhang-Salomons); Division of Cancer Care and Epidemiology (Peng, Mackillop, Booth, Zhang-Salomons), Cancer Research Institute, Queen's University, Kingston, Ont.
Abstract
BACKGROUND: Cancer survival is known to be associated with socioeconomic status. The income gap between the richer and poorer segments of the population has widened over the last 20 years in Canada. The purpose of this study was to investigate temporal trends in disparities in cancer-specific survival related to socioeconomic status in Ontario. METHODS: There were 920 334 cancer cases between 1993 and 2009 in the Ontario Cancer Registry. We linked median household income from the Canadian census to the registry. We calculated 5-year cancer-specific survival rates for all cancers combined and for specific cancer sites by socioeconomic status quintile and year of diagnosis, and modelled time to death using Cox regression. RESULTS: Between 1993 and 2009, for all cancers combined, the hazard of death decreased by 3.1% (hazard ratio [HR] 0.969 [95% confidence interval (CI) 0.967-0.971]) per year in the richest quintile and by 1.2% (HR 0.988 [95% CI 0.987-0.990]) per year in the poorest quintile. The corresponding values for breast cancer were 4.3% (HR 0.957 [95% CI 0.951-0.964]) and 2.0% (HR 0.980 [95% CI 0.975-0.986]); for lung cancer, 1.4% (HR 0.986 [95% CI 0.982-0.990]) and 0.3% (HR 0.997 [95% CI 0.995-1.000]); for colorectal cancer, 3.7% (HR 0.963 [95% CI 0.958-0.968]) and 1.8% (HR 0.982 [95% CI 0.978-0.985]); and for head and neck cancer, 3.1% (HR 0.969 [95% CI 0.958-0.979]) and 1.0% (HR 0.990 [95% CI 0.983-0.996]). INTERPRETATION: Between 1993 and 2009, cancer-specific survival in Ontario improved more among patients from affluent communities than among those from poorer communities. This phenomenon cannot be explained by increased disparity in income. Copyright 2017, Joule Inc. or its licensors.
BACKGROUND:Cancer survival is known to be associated with socioeconomic status. The income gap between the richer and poorer segments of the population has widened over the last 20 years in Canada. The purpose of this study was to investigate temporal trends in disparities in cancer-specific survival related to socioeconomic status in Ontario. METHODS: There were 920 334 cancer cases between 1993 and 2009 in the Ontario Cancer Registry. We linked median household income from the Canadian census to the registry. We calculated 5-year cancer-specific survival rates for all cancers combined and for specific cancer sites by socioeconomic status quintile and year of diagnosis, and modelled time to death using Cox regression. RESULTS: Between 1993 and 2009, for all cancers combined, the hazard of death decreased by 3.1% (hazard ratio [HR] 0.969 [95% confidence interval (CI) 0.967-0.971]) per year in the richest quintile and by 1.2% (HR 0.988 [95% CI 0.987-0.990]) per year in the poorest quintile. The corresponding values for breast cancer were 4.3% (HR 0.957 [95% CI 0.951-0.964]) and 2.0% (HR 0.980 [95% CI 0.975-0.986]); for lung cancer, 1.4% (HR 0.986 [95% CI 0.982-0.990]) and 0.3% (HR 0.997 [95% CI 0.995-1.000]); for colorectal cancer, 3.7% (HR 0.963 [95% CI 0.958-0.968]) and 1.8% (HR 0.982 [95% CI 0.978-0.985]); and for head and neck cancer, 3.1% (HR 0.969 [95% CI 0.958-0.979]) and 1.0% (HR 0.990 [95% CI 0.983-0.996]). INTERPRETATION: Between 1993 and 2009, cancer-specific survival in Ontario improved more among patients from affluent communities than among those from poorer communities. This phenomenon cannot be explained by increased disparity in income. Copyright 2017, Joule Inc. or its licensors.
Authors: Derek Grose; David S Morrison; Graham Devereux; Richard Jones; Dave Sharma; Colin Selby; Kirsty Docherty; David McIntosh; Greig Louden; Marianne Nicolson; Donald C McMillan; Robert Milroy Journal: Postgrad Med J Date: 2014-03-27 Impact factor: 2.401
Authors: Darren R Brenner; Abbey Poirier; Ryan R Woods; Larry F Ellison; Jean-Michel Billette; Alain A Demers; Shary Xinyu Zhang; Chunhe Yao; Christian Finley; Natalie Fitzgerald; Nathalie Saint-Jacques; Lorraine Shack; Donna Turner; Elizabeth Holmes Journal: CMAJ Date: 2022-06-13 Impact factor: 16.859
Authors: Nina Afshar; Dallas R English; Tony Blakely; Vicky Thursfield; Helen Farrugia; Graham G Giles; Roger L Milne Journal: PLoS One Date: 2020-01-30 Impact factor: 3.240
Authors: Heba T Mahmoud; Giuseppe Berton; Rocco Cordiano; Rosa Palmieri; Tobia Nardi; Mohammad Ak Abdel-Wahab; Fiorella Cavuto Journal: Front Oncol Date: 2021-10-14 Impact factor: 6.244
Authors: Darren R Brenner; Abbey Poirier; Ryan R Woods; Larry F Ellison; Jean-Michel Billette; Alain A Demers; Shary Xinyu Zhang; Chunhe Yao; Christian Finley; Natalie Fitzgerald; Nathalie Saint-Jacques; Lorraine Shack; Donna Turner; Elizabeth Holmes Journal: CMAJ Date: 2022-05-02 Impact factor: 16.859
Authors: Majid Taheri; Mohammad Tavakol; Mohammad Esmaeil Akbari; Amir Almasi-Hashiani; Mahmoud Abbasi Journal: Iran J Public Health Date: 2019-08 Impact factor: 1.429
Authors: Huashan Shi; Kexun Zhou; Jordan Cochuyt; David Hodge; Hong Qin; Rami Manochakian; Yujie Zhao; Sikander Ailawadhi; Alex A Adjei; Yanyan Lou Journal: Front Oncol Date: 2021-12-10 Impact factor: 6.244